| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1011954829 |
| P356 | DOI | 10.1186/1471-2407-9-389 |
| P932 | PMC publication ID | 2785835 |
| P698 | PubMed publication ID | 19886989 |
| P5875 | ResearchGate publication ID | 38065006 |
| P50 | author | John M. Luk | Q42935545 |
| Irene Oi-lin Ng | Q67487913 | ||
| P2093 | author name string | Pak C Sham | |
| Ke Hao | |||
| Hongyue Dai | |||
| Chunsheng Zhang | |||
| Mao Mao | |||
| Nikki P Y Lee | |||
| Ronnie T P Poon | |||
| John Lamb | |||
| Mark D Ferguson | |||
| P2860 | cites work | Prognosis of hepatocellular carcinoma: the BCLC staging classification | Q29619984 |
| Time-dependent ROC curves for censored survival data and a diagnostic marker | Q30600327 | ||
| Epidemiology of primary liver cancer | Q33750533 | ||
| Gene expression in fixed tissues and outcome in hepatocellular carcinoma. | Q34235518 | ||
| Gene expression-based survival prediction in lung adenocarcinoma: a multi-site, blinded validation study | Q34798314 | ||
| The Barcelona approach: diagnosis, staging, and treatment of hepatocellular carcinoma | Q35648702 | ||
| Novel concepts in hepatocellular carcinoma: from molecular research to clinical practice. | Q36610705 | ||
| Microarray-based analysis for hepatocellular carcinoma: from gene expression profiling to new challenges | Q36802501 | ||
| Biological treatment for liver tumor and new potential biomarkers. | Q36916022 | ||
| Hepatocellular carcinoma: current management and recent advances. | Q37181474 | ||
| Classification of ovarian cancer: a genomic analysis. | Q37188831 | ||
| Treatment options for hepatocellular carcinoma | Q37345911 | ||
| Liver resection for hepatocellular carcinoma: a multivariate analysis of factors associated with improved prognosis. The role of clinical, pathological and surgical related factors | Q43493681 | ||
| Risk factors and prognostic factors of local recurrence after radiofrequency ablation of hepatocellular carcinoma. | Q44215717 | ||
| A new prognostic score system in patients with advanced hepatocellular carcinoma not amendable to locoregional therapy: implication for patient selection in systemic therapy trials. | Q46318029 | ||
| Clinicopathologic features of hepatocellular carcinoma patients with compensated cirrhosis surviving more than 10 years after curative hepatectomy. | Q51770636 | ||
| Prediction of venous metastases, recurrence, and prognosis in hepatocellular carcinoma based on a unique immune response signature of the liver microenvironment. | Q53343023 | ||
| Prognostic significance of pathologic features of hepatocellular carcinoma. A multivariate analysis of 278 patients | Q71067081 | ||
| Clinicopathologic features and factors related to survival of patients with small hepatocellular carcinoma after hepatic resection | Q73049857 | ||
| Clinicopathologic features of long-term survivors and disease-free survivors after resection of hepatocellular carcinoma: a study of a prospective cohort | Q74026570 | ||
| Simplified staging for hepatocellular carcinoma | Q77768599 | ||
| Preoperative predictors of survival after resection of small hepatocellular carcinomas | Q78020869 | ||
| Predictors of microvascular invasion in patients with hepatocellular carcinoma who are candidates for orthotopic liver transplantation | Q78052589 | ||
| Prognosis of advanced hepatocellular carcinoma: comparison of three staging systems in two French clinical trials | Q80780780 | ||
| Clinical features and prognosis of hepatocellular carcinoma in young patients from a hepatitis B-endemic area | Q83200879 | ||
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | hepatocellular carcinoma | Q1148337 |
| P304 | page(s) | 389 | |
| P577 | publication date | 2009-11-03 | |
| P1433 | published in | BMC Cancer | Q326300 |
| P1476 | title | Predicting prognosis in hepatocellular carcinoma after curative surgery with common clinicopathologic parameters | |
| P478 | volume | 9 |
| Q52691760 | A novel combined systemic inflammation-based score can predict survival of intermediate-to-advanced hepatocellular carcinoma patients undergoing transarterial chemoembolization. |
| Q35889913 | A novel, externally validated inflammation-based prognostic algorithm in hepatocellular carcinoma: the prognostic nutritional index (PNI) |
| Q54321502 | CCL5-28, CCL5-403, and CCR5 genetic polymorphisms and their synergic effect with alcohol and tobacco consumptions increase susceptibility to hepatocellular carcinoma. |
| Q34341560 | Cancer-associated carbohydrate antigens as potential biomarkers for hepatocellular carcinoma. |
| Q97093992 | Circular RNA Expression Profiles and the Pro-tumorigenic Function of CircRNA_10156 in Hepatitis B Virus-Related Liver Cancer |
| Q53235978 | Clinical and biological significance of never in mitosis gene A-related kinase 6 (NEK6) expression in hepatic cell cancer. |
| Q38855661 | Clinical utility of simple non-invasive liver fibrosis indices for predicting hepatocellular carcinoma (HCC) among Egyptian patients |
| Q34070902 | Clinicopathologic and gene expression parameters predict liver cancer prognosis. |
| Q47220725 | Curcumin combined with glycyrrhetinic acid inhibits the development of hepatocellular carcinoma cells by down-regulating the PTEN/PI3K/AKT signalling pathway |
| Q28242740 | DLK1-DIO3 genomic imprinted microRNA cluster at 14q32.2 defines a stemlike subtype of hepatocellular carcinoma associated with poor survival |
| Q42227805 | Development of a novel score for early detection of hepatocellular carcinoma among high-risk hepatitis C virus patients. |
| Q34547411 | Diabetes mellitus impacts risk of macrovascular invasion in patients undergoing transplantation for hepatocellular carcinoma |
| Q39411411 | Dickkopf 4 (DKK4) acts on Wnt/β-catenin pathway by influencing β-catenin in hepatocellular carcinoma |
| Q38645087 | Downregulation of microRNA-196a inhibits human liver cancer cell proliferation and invasion by targeting FOXO1. |
| Q39711641 | Effect of Transcatheter Arterial Chemoembolization Combined with Argon-Helium Cryosurgery System on the Changes of NK Cells and T Cell Subsets in Peripheral Blood of Hepatocellular Carcinoma Patients |
| Q36544320 | Elevated expression of Cripto-1 correlates with poor prognosis in hepatocellular carcinoma |
| Q36095316 | Elevated expression of UHRF1 predicts unfavorable prognosis for patients with hepatocellular carcinoma |
| Q33547822 | Enhanced detection of early hepatocellular carcinoma by serum SELDI-TOF proteomic signature combined with alpha-fetoprotein marker. |
| Q35658230 | Establishment and Validation of SSCLIP Scoring System to Estimate Survival in Hepatocellular Carcinoma Patients Who Received Curative Liver Resection. |
| Q39332655 | GABA stimulates human hepatocellular carcinoma growth through overexpressed GABAA receptor theta subunit |
| Q36487934 | Gene expression analysis in serial liver fine needle aspirates |
| Q28740309 | Gene signatures derived from a c-MET-driven liver cancer mouse model predict survival of patients with hepatocellular carcinoma |
| Q44395085 | Genome-wide survey of recurrent HBV integration in hepatocellular carcinoma |
| Q35189366 | Hep88 mAb-initiated paraptosis-like PCD pathway in hepatocellular carcinoma cell line through the binding of mortalin (HSPA9) and alpha-enolase |
| Q45353493 | Hepatitis B virus X protein (HBx)-related long noncoding RNA (lncRNA) down-regulated expression by HBx (Dreh) inhibits hepatocellular carcinoma metastasis by targeting the intermediate filament protein vimentin |
| Q38765991 | Hepatoma-derived growth factor promotes growth and metastasis of hepatocellular carcinoma cells |
| Q47114277 | Heteroplasmy and Copy Number Variations of Mitochondria in 88 Hepatocellular Carcinoma Individuals |
| Q39411944 | High co-expression of vascular endothelial growth factor receptor-1 and Snail is associated with poor prognosis after curative resection of hepatocellular carcinoma |
| Q43545067 | High risk of lung metastasis after resection of hepatocellular carcinoma more than 7 cm in diameter |
| Q39619016 | Induction of mutant p53-dependent apoptosis in human hepatocellular carcinoma by targeting stress protein mortalin. |
| Q41602224 | Investigation of serum lncRNA-uc003wbd and lncRNA-AF085935 expression profile in patients with hepatocellular carcinoma and HBV. |
| Q39404230 | Large intervening non-coding RNA HOTAIR is associated with hepatocellular carcinoma progression |
| Q33661229 | LncRNAs expression signatures of hepatocellular carcinoma revealed by microarray |
| Q89847002 | Long non-coding RNA GAS6-AS1 acts as a ceRNA for microRNA-585, thereby increasing EIF5A2 expression and facilitating hepatocellular carcinoma oncogenicity |
| Q45334856 | Long noncoding RNA high expression in hepatocellular carcinoma facilitates tumor growth through enhancer of zeste homolog 2 in humans |
| Q92643942 | MRI-based radiomics model for preoperative prediction of 5-year survival in patients with hepatocellular carcinoma |
| Q89687442 | MiR-135b-5p promotes viability, proliferation, migration and invasion of gastric cancer cells by targeting Krüppel-like factor 4 (KLF4) |
| Q28658442 | MiR-182 is up-regulated and targeting Cebpa in hepatocellular carcinoma |
| Q83976192 | MicroRNA-10b promotes migration and invasion through CADM1 in human hepatocellular carcinoma cells |
| Q35145191 | MicroRNA-338-3p inhibits cell proliferation in hepatocellular carcinoma by target forkhead box P4 (FOXP4) |
| Q42835046 | MicroRNA-345 inhibits hepatocellular carcinoma metastasis by inhibiting YAP1. |
| Q36640289 | Natural killer cells inhibit pulmonary metastasis of hepatocellular carcinoma in nude mice |
| Q36125548 | Persistent increase in alpha-fetoprotein level in a patient without underlying liver disease who underwent curative resection of hepatocellular carcinoma. A case report and review of the literature |
| Q34991323 | Postoperative adjuvant transcatheter arterial chemoembolization for resectable multiple hepatocellular carcinoma beyond the Milan criteria: a retrospective analysis |
| Q42362664 | Prediction of early recurrence of hepatocellular carcinoma within the Milan criteria after radical resection |
| Q37954232 | Prediction of microvascular invasion of hepatocellular carcinoma: usefulness of peritumoral hypointensity seen on gadoxetate disodium-enhanced hepatobiliary phase images. |
| Q28742950 | Predictive genes in adjacent normal tissue are preferentially altered by sCNV during tumorigenesis in liver cancer and may rate limiting |
| Q47738876 | Prognostic value of serum MMP-8, -9 and TIMP-1 in patients with hepatocellular carcinoma |
| Q40101875 | Role of the long non-coding RNA HOTAIR in hepatocellular carcinoma |
| Q87344337 | Serglycin (SRGN) overexpression predicts poor prognosis in hepatocellular carcinoma patients |
| Q92840574 | Significance of incorporation of DNMT1 and HLA-DRα with TNM staging in patients with hepatocellular carcinoma after curative resection |
| Q33403504 | Small hepatocellular carcinomas and thrombocytopenia |
| Q88027699 | TIMP-3 -1296 T>C and TIMP-4 -55 T>C gene polymorphisms play a role in the susceptibility of hepatocellular carcinoma among women |
| Q35206951 | The long noncoding RNA expression profile of hepatocellular carcinoma identified by microarray analysis |
| Q37915623 | Tripterygium wilfordii bioactive compounds as anticancer and anti-inflammatory agents. |
| Q34979073 | Two-tiered approach identifies a network of cancer and liver disease-related genes regulated by miR-122. |
| Q57165704 | Upregulation of miR-375 inhibits human liver cancer cell growth by modulating cell proliferation and apoptosis via targeting ErbB2 |
| Q95936514 | lncRNA-SOX2OT promotes hepatocellular carcinoma invasion and metastasis through miR-122-5p-mediated activation of PKM2 |
| Q36771909 | miR-192, a prognostic indicator, targets the SLC39A6/SNAIL pathway to reduce tumor metastasis in human hepatocellular carcinoma |
| Q33670786 | miR-539 inhibits FSCN1 expression and suppresses hepatocellular carcinoma migration and invasion |
| Q35167131 | miR-630 overexpression in hepatocellular carcinoma tissues is positively correlated with alpha-fetoprotein |
| Q24595141 | microRNA-122 as a regulator of mitochondrial metabolic gene network in hepatocellular carcinoma |
| Q92648977 | microRNA-548b suppresses aggressive phenotypes of hepatocellular carcinoma by directly targeting high-mobility group box 1 mRNA |
Search more.